This treatment is not suitable for individuals who are pregnant/breastfeeding, or those with pacemakers, heart conditions, active thrombosis, diabetes, epilepsy, auto-immune conditions, or active skin infections (psoriasis/eczema) in the treatment area
GLP-1 also plays a crucial role in regulating blood sugar levels
Klein EA, Thompson IM Jr, Tangen CM, et al
UCHealths guidance for people using GLP-1 weight-loss drugs emphasizes protein, fiber, and hydration, and notes that smaller, more frequent meals can help people tolerate eating while appetite is reduced
It promotes semaglutide monomer formation by disrupting peptide self-aggregation, increasing the effective concentration of absorbable drug